Jump to main content
Jump to site search

Issue 5, 2014
Previous Article Next Article

Recent trends in the design of anticancer polymer prodrug nanocarriers

Author affiliations

Abstract

Nanocarriers based on polymers have attracted much attention to perform drug delivery, especially in cancer therapy. Although significant advances have been reported, important obstacles still remain with the use of encapsulated anticancer drugs in polymer nanoparticles (e.g., ‘burst release’, poor drug loading, low miscibility of certain drugs with the polymer matrix). To solve these issues, synthetic strategies orientated toward the prodrug approach, whereby the drug is covalently linked to the polymer scaffold, have been investigated and are detailed in the present review. It will focus on recent synthetic strategies to achieve drug–polymer conjugate nanoassemblies as well as their biological evaluations.

Graphical abstract: Recent trends in the design of anticancer polymer prodrug nanocarriers

Back to tab navigation

Publication details

The article was received on 02 Oct 2013, accepted on 25 Oct 2013 and first published on 29 Oct 2013


Article type: Review Article
DOI: 10.1039/C3PY01384G
Polym. Chem., 2014,5, 1529-1544

  •   Request permissions

    Recent trends in the design of anticancer polymer prodrug nanocarriers

    V. Delplace, P. Couvreur and J. Nicolas, Polym. Chem., 2014, 5, 1529
    DOI: 10.1039/C3PY01384G

Search articles by author

Spotlight

Advertisements